Notice of AGM
17/05/2022 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220517:nRSQ6811La&default-theme=true
RNS Number : 6811L RTW Venture Fund Limited 17 May 2022
LEI: 549300Q7EXQQH6KF7Z84
17 May 2022
RTW Venture Fund Limited
Notice of Annual General Meeting
RTW Venture Fund Limited (the "Company") announces that its Annual General
Meeting ("AGM") will be held at 1(st) Floor Royal Chambers, St Julian's
Avenue St Peter Port, Guernsey on 21 June 2022 at 2pm BST. The Notice of
AGM will shortly be dispatched to all shareholders.
A copy of the Notice of AGM has been submitted to the National Storage
Mechanism and will shortly be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) The Notice of AGM may
also be viewed on the Company's website
at https://www.rtwfunds.com/venture-fund/
(https://www.rtwfunds.com/venture-fund/) .
The Annual Report and Audited Financial Statements for the year ended 31
December 2021 (the "Annual Report") is also available on the Company's
website https://www.rtwfunds.com/venture-fund/
(https://www.rtwfunds.com/venture-fund/) at and on the National Storage
Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
The Board anticipates that at the time of the Annual General Meeting
Shareholders will be able to attend the meeting in person, subject to any
COVID-19 restrictions that might be imposed by the States of Guernsey. You
will not have received a hard copy proxy form for the AGM in the post. You can
instead submit your proxy vote electronically by accessing the shareholder
portal at www.signalshares.com, logging in and selecting the 'Vote Online Now'
link. Full details of how to vote are set out in the Notes to the Notice of
Meeting. Please submit your proxy vote so as to reach the Company's registrar
as soon as possible and in any event no later than 2pm BST on 17 June 2022 or,
if you are a CREST member, by using the service provided by Euroclear. The
completion of the form of proxy will not preclude a member from attending and
voting in person at the meeting if it is so allowed.
If any shareholder has questions related to the business of the AGM, please
submit your queries at https://www.rtwfunds.com/venture-fund/
(https://www.rtwfunds.com/venture-fund/) by 2pm BST on 17 June 2022. We
will endeavour to answer every shareholder question and responses will be
posted on the Company's website after the AGM.
For Further Information
RTW Investments,
LP
+1 (646) 597 6980
Stephanie Sirota, Chief Business Officer
Woody Stileman, Managing Director
Elysium Fund Management Limited +44 (0) 14 8181 0100
Joanna Duquemin Nicolle, Chief Executive Officer
Sadie Morrison, Managing Director
J.P. Morgan Cazenove
+44 (0)20 7742 4000
William Simmonds
Jérémie Birnbaum
James Bouverat (Sales)
BofA Securities
+44 (0) 20 7628 1000
Edward Peel
Kieran Millar
About RTW Venture Fund Limited:
RTW Venture Fund Limited (LSE: RTW & RTWG) is an investment fund focused
on identifying transformative assets with high growth potential across the
biopharmaceutical and medical technology sectors. Driven by a long-term
approach to support innovative businesses, RTW Venture Fund Limited invests in
companies developing next-generation therapies and technologies that can
significantly improve patients' lives.
RTW Venture Fund Limited is managed by RTW Investments, LP, a leading
healthcare-focused entrepreneurial investment firm with deep scientific
expertise and a strong track record of supporting companies developing
life-changing therapies.
Visit the RTW website at www.rtwfunds.com
(https://protect.mimecast-offshore.com/s/eY8OCgLEp4SlY4JEFN_vEF) for more
information.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOASFIFMMEESEDI